Business
Zydus Lifesciences Q4 Result FY26: Stellar Earnings Beat, ₹1,100 Crore Buyback Sparks Pharma Rally
Pharmaceutical giant Zydus Lifesciences sent shockwaves through Dalal Street today, turning what was expected to be a routine Q4 FY26…
Pharmaceutical giant Zydus Lifesciences sent shockwaves through Dalal Street today, turning what was expected to be a routine Q4 FY26…